Financier | Commitments |
---|---|
IDA Credit | 20.00 |
Global Financing Facility | 5.00 |
P174185
Closed
John Makumba , Fernando Montenegro Torres
Republic of Zambia
October 20, 2020
(as of board presentation)
October 20, 2020
January 12, 2021
US$ 25.00 million
Ministry of Health,Zambia National Public Health Institute
2021
US$ 25.00 million
N/A
February 12, 2024
December 31, 2024
Yes
BANK APPROVED
Financier | Commitments |
---|---|
IDA Credit | 20.00 |
Global Financing Facility | 5.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 20.00 |
IBRD + IDA Commitment | 20.00 |
Lending Instrument | |
---|---|
Grant Amount | 5.00 |
Total Project Cost** | 25.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Oct 20, 2020 | IDA-67750 | Loan Commitment | 20,000,000.00 |
Jun 28, 2021 | IDA-69680 | Loan Commitment | 14,000,000.00 |
Dec 7, 2023 | IDA-67750 | Loan Disb | 270,431.25 |
Dec 7, 2023 | IDA-67750 | Loan Disb | 88,754.72 |
Nov 22, 2023 | IDA-67750 | Int Charges | 746.21 |
Nov 22, 2023 | IDA-67750 | Int Charges | 37,286.14 |
Nov 22, 2023 | IDA-67750 | Int Charges | 37,286.14 |
Nov 22, 2023 | IDA-67750 | Int Charges | 61,025.36 |
Oct 18, 2023 | IDA-67750 | Loan Disb | 102,020.00 |
Jul 23, 2024 | IDA-67750 | Loan Disb | 92,708.38 |
May 8, 2024 | IDA-67750 | Loan Disb | 249,408.12 |
Apr 5, 2024 | IDA-67750 | Loan Disb | 21,652.84 |
Apr 15, 2024 | IDA-67750 | Loan Disb | 40,881.53 |
Apr 12, 2024 | IDA-67750 | Loan Disb | 217,480.64 |
Nov 21, 2023 | IDA-67750 | Loan Disb | 54,413.86 |
Apr 24, 2024 | IDA-67750 | Loan Disb | 47,504.56 |
Mar 15, 2024 | IDA-69680 | Int Charges | 1,818.74 |
Mar 7, 2024 | IDA-67750 | Loan Disb | 92,576.82 |
Mar 18, 2024 | IDA-69680 | Int Charges | 55,795.52 |
Mar 18, 2024 | IDA-69680 | Int Charges | 31,658.56 |
Mar 18, 2024 | IDA-69680 | Int Charges | 31,658.56 |
Mar 15, 2024 | IDA-69680 | Int Charges | 1,818.74 |
Feb 9, 2024 | IDA-67750 | Loan Disb | 41,338.62 |
Feb 21, 2024 | IDA-67750 | Loan Disb | 40,942.80 |
Aug 16, 2024 | IDA-67750 | Loan Disb | 7,103.84 |
May 16, 2024 | IDA-67750 | Loan Disb | 29,640.00 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 39,495.17 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 604,728.50 |
Sep 6, 2023 | IDA-67750 | Loan Disb | 204,040.00 |
Sep 7, 2023 | IDA-67750 | Loan Disb | 3,000.00 |
May 30, 2023 | IDA-67750 | Loan Disb | 405,700.56 |
Sep 19, 2023 | IDA-69680 | Int Charges | 26,548.96 |
Sep 19, 2023 | IDA-69680 | Int Charges | 26,548.96 |
Aug 29, 2023 | IDA-67750 | Loan Disb | 337,475.25 |
Sep 19, 2023 | IDA-69680 | Int Charges | 44,248.24 |
Nov 15, 2023 | IDA-67750 | Loan Disb | 66,540.18 |
Jan 4, 2024 | IDA-67750 | Loan Disb | 588,191.30 |
Jan 4, 2024 | IDA-67750 | Loan Disb | 161,699.60 |
Oct 25, 2023 | IDA-67750 | Loan Disb | 41,146.62 |
Jan 3, 2024 | IDA-67750 | Loan Disb | 163,783.22 |
Nov 24, 2021 | IDA-67750 | Int Charges | 6,596.09 |
Nov 24, 2021 | IDA-67750 | Int Charges | 6,596.09 |
Nov 24, 2021 | IDA-67750 | Int Charges | 10,993.52 |
Jun 30, 2021 | IDA-67750 | Loan Disb | 2,400,000.00 |
Mar 14, 2022 | IDA-67750 | Loan Disb | 854,261.75 |
May 15, 2022 | IDA-67750 | Int Charges | 405.07 |
May 15, 2022 | IDA-67750 | Int Charges | 405.07 |
Jun 9, 2022 | IDA-67750 | Int Charges | 16,367.21 |
Jun 9, 2022 | IDA-67750 | Int Charges | 9,529.26 |
Jun 9, 2022 | IDA-67750 | Int Charges | 9,529.26 |
May 2, 2022 | IDA-67750 | Loan Disb | 1,146,444.20 |
Jun 23, 2022 | IDA-67750 | Loan Disb | 1,270,850.50 |
Mar 7, 2022 | IDA-67750 | Loan Disb | 51,990.74 |
Nov 7, 2022 | IDA-67750 | Loan Disb | 119,809.51 |
Nov 7, 2022 | IDA-67750 | Loan Disb | 57,937.66 |
Nov 18, 2022 | IDA-67750 | Loan Disb | 190,535.94 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 4,956.54 |
Jun 28, 2024 | IDA-67750 | Loan Disb | 36,674.10 |
Jun 24, 2024 | IDA-67750 | Loan Disb | 43,231.35 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 40,572.42 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 63,948.29 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 364,214.30 |
May 21, 2024 | IDA-67750 | Loan Disb | 194,828.12 |
Jun 27, 2024 | IDA-67750 | Loan Disb | 786,271.20 |
May 13, 2024 | IDA-67750 | Loan Disb | 41,486.78 |
May 15, 2024 | IDA-67750 | Int Charges | 1,111.80 |
May 15, 2024 | IDA-67750 | Int Charges | 45,222.58 |
May 15, 2024 | IDA-67750 | Int Charges | 45,222.58 |
May 15, 2024 | IDA-67750 | Int Charges | 75,370.92 |
Aug 1, 2024 | IDA-67750 | Loan Disb | 112,404.80 |
Jun 6, 2024 | IDA-67750 | Loan Disb | 311,724.97 |
Apr 23, 2024 | IDA-67750 | Loan Disb | 58,603.77 |
Jun 6, 2024 | IDA-67750 | Loan Disb | 50,451.30 |
Jul 1, 2024 | IDA-67750 | Loan Disb | -63,884.30 |
Dec 23, 2022 | IDA-67750 | Loan Disb | 179,714.27 |
Dec 23, 2022 | IDA-67750 | Loan Disb | 90,876.62 |
May 16, 2023 | IDA-67750 | Int Charges | 29,533.11 |
May 16, 2023 | IDA-67750 | Int Charges | 29,533.11 |
Apr 21, 2023 | IDA-69680 | Loan Disb | 9,037,630.00 |
Feb 16, 2023 | IDA-67750 | Loan Disb | 320,300.56 |
Dec 20, 2022 | IDA-67750 | Loan Disb | 867,335.25 |
Dec 16, 2022 | IDA-67750 | Loan Disb | 277,619.97 |
Nov 25, 2022 | IDA-67750 | Int Charges | 192.48 |
Nov 25, 2022 | IDA-67750 | Int Charges | 19,534.58 |
Nov 25, 2022 | IDA-67750 | Int Charges | 19,534.58 |
Nov 25, 2022 | IDA-67750 | Int Charges | 31,536.79 |
Nov 3, 2022 | IDA-67750 | Loan Disb | 400,331.62 |
Nov 7, 2022 | IDA-67750 | Loan Disb | 185,079.98 |
Aug 3, 2023 | IDA-67750 | Loan Disb | 65,209.62 |
Sep 8, 2023 | IDA-67750 | Loan Disb | 310,875.56 |
Aug 1, 2023 | IDA-67750 | Loan Disb | 205,362.44 |
May 16, 2023 | IDA-67750 | Int Charges | 1,047.79 |
May 16, 2023 | IDA-67750 | Int Charges | 48,468.63 |
May 18, 2023 | IDA-67750 | Loan Disb | 519,361.70 |
Jun 30, 2023 | IDA-67750 | Loan Disb | 378,544.22 |
Sep 6, 2023 | IDA-67750 | Loan Disb | 62,209.63 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Moderately Satisfactory | 2024-08-25 |
Financial Management | Moderately Satisfactory | 2024-08-25 |
Monitoring and Evaluation | Moderately Satisfactory | 2024-08-25 |
Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-08-25 |
Procurement | Moderately Satisfactory | 2024-08-25 |
Project Management | Moderately Satisfactory | 2024-08-25 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of designated laboratories with SARS-CoV-2 diagnostic capacity (Number) | Value | 3.00 | 17.00 | 25.00 |
Date | December 30, 2019 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of designated health facilities with COVID-19 case management capacity | Value | 3.00 | 50.00 | 25.00 |
Date | December 31, 2019 | June 2, 2023 | June 30, 2024 | |
Comment |
Proportion of eligible population fully vaccinated, which is included in the priority targets defined in the National Plan (by gender) | Value | 0.00 | 85.50 | 90.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Quarterly number of first Outpatient Department (OPD) consultations [by Gender] (Number) | Value | 5525000.00 | 2298523.00 | 2400000.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of designated laboratories with capacity for genomic sequencing | Value | 0.00 | 5.00 | 3.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Monthly average number of infants receiving 3 doses of Pentavalent vaccine | Value | 50000.00 | 53530.00 | 55000.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Key messages and materials developed for public communications and advocacy, in alignment with demand plan, and establishing two-way feedback and response mechanisms | Value | NO | YES | YES |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of health workers trained trained in IPC interventions | Value | 5500.00 | 5600.00 | 5700.00 |
Date | December 30, 2022 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of fully equipped provincial blood storage hubs established and operational in compliance with national standards | Value | 0.00 | 0.00 | 6.00 |
Date | November 30, 2023 | November 30, 2023 | June 30, 2024 | |
Comment |
Percentage of designated hospitals with functional oxygen delivery equipment | Value | 0.00 | 37.00 | 60.00 |
Date | December 30, 2019 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of operational research studies conducted to inform the national COVID-19 response | Value | 0.00 | 0.00 | 3.00 |
Date | December 30, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of dedicated quarantine and isolation centers | Value | 3.00 | 48.00 | 80.00 |
Date | December 30, 2019 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of health workers trained in COVID-19 case management [by gender] | Value | 0.00 | 1601.00 | 5000.00 |
Date | December 30, 2019 | June 2, 2023 | June 30, 2024 | |
Comment |
Annual joint review of project implementation | Value | 0.00 | 1.00 | 2.00 |
Date | April 30, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Preparation of Bi-annual report on project beneficiaries’ feed-backs and resolutions | Value | NO | YES | YES |
Date | May 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Percentage of designated health facilities with an improved water source on premises | Value | 40.00 | 0.00 | 60.00 |
Date | December 31, 2019 | June 2, 2023 | June 30, 2024 | |
Comment |
DHIS2 COVID-19 Vaccine delivery Tool Kit implemented (YES/No) | Value | NO | NO | YES |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of health workers who are fully vaccinated against COVID-19 [by gender] | Value | 0.00 | 83750.00 | 60000.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Number of Health Facilities equipped with energy efficient storage facilities for vaccines and temperature sensitive medical supplies | Value | 0.00 | 0.00 | 1500.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |
Monthly average number of deliveries attended by skilled personnel | Value | 47000.00 | 43633.00 | 50000.00 |
Date | December 31, 2020 | June 2, 2023 | June 30, 2024 | |
Comment |